LINDAHL RICHARD S 4
4 · Emergent BioSolutions Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Emergent BioSolutions (EBS) CFO Richard Lindahl Receives Award
What Happened
Richard S. Lindahl, Chief Financial Officer of Emergent BioSolutions Inc., was granted 162,680 restricted stock units (RSUs) on April 29, 2026. The Form 4 reports the acquisition price as $0.00 (typical for RSU awards) and lists the transaction as an award rather than a purchase or sale.
Key Details
- Transaction date: 2026-04-29; reported acquisition type: Award (Code A); reported price: $0.00.
- Award size: 162,680 restricted stock units (each RSU represents the right to one share upon vesting).
- Shares owned after transaction: Not specified in this Form 4 filing.
- Approval: Grant was approved by the Compensation Committee on March 2, 2026, subject to and following stockholder approval of an amendment to the 2006 Stock Incentive Plan; stockholders approved the amended plan on April 29, 2026. (See footnotes.)
- Vesting: RSUs vest in three annual installments beginning on the anniversary of the approval date, subject to continued service.
- Filing timeliness: Form 4 filed May 1, 2026, which appears to be within the standard two-business-day reporting window.
Context
This is a compensation award (RSUs), not an open-market buy or sale. RSUs only convert to actual shares (and potential liquidity) as they vest and are typically subject to continued employment and the plan/grant terms. Such grants are common executive compensation and are not by themselves a direct market signal.
Insider Transaction Report
Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
[F1][F2]2026-04-29+162,680→ 378,047 total
Footnotes (2)
- [F1]The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the "Company"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the "Amended Stock Incentive Plan"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026.
- [F2]Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Signature
/s/ Richard S. Lindahl|2026-05-01